IMMIX BIOPHARMA, INC.

Sector revisions Immix Biopharma, Inc.

Equities

IMMX

US45258H1068

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 04:00:00 2025-12-15 pm EST			5-day change	1st Jan Change
6.205 ^USD	-12.23%		+0.89%	+182.05%

Dec. 09	Immix Biopharma announces closing of upsized $100 million underwritten offering of common stock and pre-funded warrants	RE
Dec. 08	Immix Biopharma Prices $100 Million Offering	MT

Sector:

Location:

X axis:

Main competitors

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	4m. EPS revision	4m. Revenue rev.	1y. EPS revision	1y. Revenue rev.	Visibility	Nbr of analysts
	IMMIX BIOPHARMA, INC.	-		-		-		2
	ARGENX SE							13
	INSMED INCORPORATED							18
	WUXI APPTEC CO., LTD.							19
	BIONTECH SE							19
	GENMAB A/S							14
	WUXI BIOLOGICS (CAYMAN) INC.							25
	AKESO, INC.							21
	SUMMIT THERAPEUTICS INC.							13
	SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.							17
	MADRIGAL PHARMACEUTICALS, INC.							15
	EXELIXIS, INC.							18
	ARROWHEAD PHARMACEUTICALS, INC.							12
	NUVALENT, INC.							17
	CYTOKINETICS, INCORPORATED							18
	MERUS N.V.							12
	Average							16
	Weighted average by Cap.							17

Bio Therapeutic Drugs

The best tools reserved for subscribers to boost the performance of your investments!

Optimize my profits

Optimize my profits